Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To estimate the proportions of acute care inpatient admissions and hospital days for schizophrenia patients in the Medicaid program that are attributable to gaps in outpatient antipsychotic treatment and to calculate the corresponding total health care costs of this care. METHODS: A series of multivariate regressions were performed with statewide 2001-2003 California Medicaid data to estimate the fraction of acute care hospital admissions and hospital days for schizophrenia attributable to gaps in antipsychotic medication treatment. This fraction was then applied to national estimates of the number and costs of inpatient treatment episodes for patients with schizophrenia in the national Medicaid program. RESULTS: In the United States, there are roughly 87 000 annual acute care inpatient admissions of Medicaid patients for the treatment of schizophrenia. These admissions include a total of approximately 930 000 hospital days at a total cost of $806 million. Improving adherence to eliminate gaps in antipsychotic medication treatment could lower the number of acute care admissions by approximately 12.3% (95% confidence interval [CI]: 11.7%-12.6%) and reduce the number of inpatient treatment days by approximately 13.1% (CI: 9.8%-16.5%) resulting in a savings of approximately $106 million (95% CI: $79.0 million-$133.0 million) in inpatient care costs for the national Medicaid system. CONCLUSIONS: Nonadherence to antipsychotic medication treatment accounts for a considerable proportion of inpatient treatment costs of Medicaid patients with schizophrenia. Improving continuity of antipsychotic medications could lead to savings by reducing the frequency and duration of inpatient treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discovering the Neural Basis of Human Social Anxiety: A Diagnostic and Therapeutic Imperative
Charney, D. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.1 · Cited by 1,428
Clinical correlates of inpatient suicide
Busch, K. A., Fawcett, J., & Jacobs, D. G. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0105 · Cited by 750
Weiden, P. J., Kozma, C., Grogg, A., & Locklear, J. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.8.886 · Cited by 621
Gilmer, T. P., Dolder, C. R., Lacro, J. P., Folsom, D. P., Lindamer, L., Garcia, P., & Jeste, D. V. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.692 · Cited by 603
Svarstad, B. L., Shireman, T. I., & Sweeney, J. K. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.6.805 · Cited by 281
Cited by
Global economic burden of schizophrenia: a systematic review
Chaiyakunapruk, N., Chong, H. Y., Teoh, S. L., Wu, D. B.-C., Kotirum, S., & Chiou, C.-F. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s96649 · Cited by 643
Higashi, K., Medic, G., Littlewood, K. J., Diez, T., Granström, O., & De Hert, M. (2013) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125312474019 · Cited by 574
The cost of relapse and the predictors of relapse in the treatment of schizophrenia
Ascher-Svanum, H., Zhu, B., Faries, D. E., Salkever, D., Slade, E. P., Peng, X., & Conley, R. R. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-2 · Cited by 275
Long-Term Effects of Brief Acceptance and Commitment Therapy for Psychosis
Bach, P., Hayes, S. C., & Gallop, R. (2012) · Behavior Modification · doi:10.1177/0145445511427193 · Cited by 97
Serving Persons With Severe Mental Illness in Primary Care–Based Medical Homes
Domino, M. E., Wells, R., & Morrissey, J. P. (2015) · Psychiatric Services · doi:10.1176/appi.ps.201300546 · Cited by 45
Metadata
- Authors
- Marcus, S. C., & Olfson, M.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-10-27
- Volume
- 34
- Issue
- 1
- Pages
- 173-180
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W2136649501
- Cited by
- 114
- References
- 5
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia. https://app.cochat.ai/papers/10.1093/schbul/sbm061
- The paper
- Marcus, S. C., & Olfson, M. (2007). Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbm061
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.